Phase 2
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Locally Advanced Breast Cancer (LABC)
Both
Locally Advanced Breast Cancer (LABC)
Trial Information
Inclusion Criteria
Documented late stage breast cancer: stage III A-B (excluding inflammatory breast
carcinoma) or localized stage IV breast cancer
Male or female
18 years or older
Adequate bone marrow, liver, and kidney function
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Authority:
United States: Food and Drug Administration
Study ID:
INT 201-010
NCT ID:
NCT00286247
Start Date:
Completion Date:
Related Keywords:
- Locally Advanced Breast Cancer (LABC)
- Breast Neoplasms
Name | Location |
|---|---|
| M.D. Anderson Cancer Center | Houston, Texas 77030 |
